Billionaire-Backed Push for Brainless Clones Raises Ethical and Scientific Red Flags
This story seems to be from the Babylon Bee, but it is not. These “scientists”, fully steeped in the mind of a Technocrat, are on a fool’s errand to create brainless clones or “organ sacks” as long as the money holds out.
The larger problem is the billionaires who shovel the money at them in the vain hope of escaping death. They are all deluded and, like the blind leading the blind, both are destined to fall into the pit.
Cloning grabbed headlines in the 1990s when Dolly the sheep became the first mammal cloned from an adult somatic cell. That breakthrough sparked a long, uneven drive to repeat the feat in other species and to push the boundaries of developmental biology.
Moving from animal embryos to human embryos has been especially controversial and legally fraught. Researchers have so far produced human embryo models grown from stem cells and cloned primates from fetal cells, rather than adult cells like Dolly. The leap to human adult-cell cloning remains blocked by ethics, law, and biology.
Recently, a stealth startup called R3 Bio, backed by wealthy investors, said it was raising money to develop non-sentient monkey “organ sacks.” The pitch, presented as an alternative to traditional animal testing, imagines structures containing organs but excluding the brain to supply donor tissues.
Those proposed organ-only bodies would, in theory, provide transplantable organs without the complications of intact animals. The framing highlights practical and moral claims at once: reduced animal suffering on one side, uncanny human engineering on the other.
According to a longer investigation, though, R3’s founders allegedly discussed something far more radical: building entire “brainless clones” of the human body as future recipients for transplanted brains. One argued that omitting brain development could sidestep certain ethical objections about creating sentient donor humans.
Such ideas are naturally polarizing. An insider described hearing a pitch compared to a “close encounter of the third kind” with “Dr. Strangelove,” and the company has publicly distanced itself from the notion of brainless human clones.
The company said its founder “never made any statement regarding hypothetical ‘non-sentient human clones’ [that] would be carried by surrogates” and insisted that “any allegations of intent or conspiracy to create human clones or humans with brain damage are categorically false.”
Still, a cofounder acknowledged the team might entertain speculative scenarios, noting the “team reserves the right to hold hypothetical futuristic discussions” about such concepts. That phrasing keeps the possibility on the table without committing to action.
Scientists and ethicists point out steep biological and regulatory obstacles. “There are so many barriers,” one researcher said, citing illegality, safety issues, and the absence of a functioning artificial womb as immediate showstoppers.
Practical hurdles go beyond technology: “You’d have to convince a woman to carry a fetus that is going to be abnormal,” the same expert added. Public acceptance, medical risk, and legal prohibitions make the whole plan look distant at best and reckless at worst.
Still, the founders appear undeterred, and one of them has discussed the idea privately for years while seeking investor interest. He wrote in a message that “We will try to do it in a way that produces defined societal benefits early on, and we need to be prepared to take no for an answer, if it turns out that this cannot be done safely,” and has declined to speak publicly until proponents can show the benefits are “reasonably grounded in reality.”